NCT03684447View on ClinicalTrials.gov

Neural and Antidepressant Effects of Propofol

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 21, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

July 31, 2024

Conditions
Treatment Resistant Depression
Interventions
DRUG

Propofol

Series of 6 treatments with propofol.

DRUG

Propofol

Series of 6 treatments with propofol. May be able to cross over and receive 6 additional treatments with the high dose of propofol.

Trial Locations (1)

84108

University Neuropsychiatric Institute, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER